Adamas to announce fourth quarter and year-end 2020 financial results and host conference call on february 23, 2021

Emeryville, calif.--(business wire)--adamas pharmaceuticals, inc. (nasdaq: adms) today announced that the company will report fourth quarter and year-end 2020 financial results on tuesday, february 23, 2021, after market close. subsequently, adamas’ management team will host a conference call and webcast at 4:30 p.m. eastern time to discuss the financial results and provide a corporate update. investor conference call and webcast the conference call can be accessed by dialing 1-877-407-9716 for participants in the u.s. or canada and 1-201-493-6779 for international callers. all callers must provide the following conference id: 13716505. the webcast can be accessed live via the investor section of the adamas website at https://ir.adamaspharma.com/events-presentations and will be available for replay for approximately 30 days. about adamas pharmaceuticals, inc. at adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. we are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. for more information, please visit www.adamaspharma.com. source: adamas pharmaceuticals, inc.
ADMS Ratings Summary
ADMS Quant Ranking